| Cutaneous immune-related adverse events are associated with longer overall survival in advanced cancer patients on immune checkpoint inhibitors: a multi-institutional cohort study S Zhang, K Tang, G Wan, N Nguyen, C Lu, P Ugwu-Dike, N Raval, J Seo, ... Journal of the American Academy of Dermatology 88 (5), 1024-1032, 2023 | 18 | 2023 |
| Prediction of early-stage melanoma recurrence using clinical and histopathologic features G Wan, N Nguyen, F Liu, MS DeSimone, BW Leung, A Rajeh, MR Collier, ... NPJ precision oncology 6 (1), 79, 2022 | 17 | 2022 |
| A polygenic risk score for predicting racial and genetic susceptibility to prurigo nodularis C Vasavda, G Wan, MD Szeto, M Marani, N Sutaria, A Rajeh, C Lu, ... Journal of Investigative Dermatology 143 (12), 2416-2426. e1, 2023 | 13 | 2023 |
| Pre-existing autoimmune disease and mortality in patients treated with anti-PD-1 and anti-PD-L1 therapy K Tang, BC Tiu, G Wan, S Zhang, N Nguyen, B Leung, A Gusev, ... Journal of the National Cancer Institute 114 (8), 1200-1202, 2022 | 12 | 2022 |
| Influence of melanoma type on incidence and downstream implications of cutaneous immune-related adverse events in the setting of immune checkpoint inhibitor therapy N Nguyen, G Wan, P Ugwu-Dike, NA Alexander, N Raval, S Zhang, ... Journal of the American Academy of Dermatology 88 (6), 1308-1316, 2023 | 9 | 2023 |
| An observational study on the molecular profiling of primary melanomas reveals a progression dependence on mitochondrial activation J Gil, M Rezeli, EG Lutz, Y Kim, Y Sugihara, J Malm, YR Semenov, KH Yu, ... Cancers 13 (23), 6066, 2021 | 6 | 2021 |
| Increased risk of cutaneous immune-related adverse events in patients treated with talimogene laherparepvec and immune checkpoint inhibitors: A multi-hospital cohort study BW Leung, G Wan, N Nguyen, H Rashdan, S Zhang, W Chen, S Cohen, ... Journal of the American Academy of Dermatology 88 (6), 1265-1270, 2023 | 2 | 2023 |
| Differences in risk of tetracycline-associated hyperpigmentation between racial and ethnic groups in patients with acne vulgaris: A national US retrospective study K Young, AD Pagan, J Yoon, E Getachew, B Leung, N Nguyen, ... Journal of the American Academy of Dermatology 88 (4), 872-875, 2023 | 2 | 2023 |
| Identification of cutaneous immune-related adverse events by International Classification of Diseases codes and medication administration W Chen, G Wan, N Nguyen, B Leung, J Wen, MR Collier, SG Kwatra, ... JAAD international 9, 112, 2022 | 2 | 2022 |
| 658 Clinical and histopathologic risk factors for early-stage melanoma recurrence B Leung, N Nguyen, MS Choi, M DeSimone, G Wan, S Zhang, A Rajeh, ... Journal of Investigative Dermatology 142 (8), S113, 2022 | 2 | 2022 |
| 649 CNN-based histopathology image analysis for early-stage melanoma recurrence G Wan, M DeSimone, F Liu, N Nguyen, B Leung, MS Choi, A Bruce, ... Journal of Investigative Dermatology 142 (8), S112, 2022 | 2 | 2022 |
| Geriatric Vulvar Dermatology N Nguyen, S Corley Current Geriatrics Reports 9, 183-191, 2020 | 2 | 2020 |
| Cancer Type and Histology Influence Cutaneous Immunotherapy Toxicities: A Multi-Institutional Cohort Study G Wan, S Khattab, BW Leung, S Zhang, N Nguyen, M Tran, C Lin, ... British Journal of Dermatology, ljae053, 2024 | 1 | 2024 |
| Development and validation of time-to-event models to predict metastatic recurrence of localized cutaneous melanoma G Wan, BW Leung, MS DeSimone, N Nguyen, A Rajeh, MR Collier, ... Journal of the American Academy of Dermatology 90 (2), 288-298, 2024 | 1 | 2024 |
| Pre-existing inflammatory disease predicts cutaneous immunotherapy toxicity development: A multi-institutional cohort study G Wan, N Nguyen, BW Leung, H Rashdan, K Tang, K Roster, MR Collier, ... Journal of the American Academy of Dermatology 90 (2), 418-420, 2024 | 1 | 2024 |
| Mitochondrial and immune response dysregulation in melanoma recurrence L Szadai, J de Siqueira Guedes, N Woldmar, NP de Almeida, ÁJ Jánosi, ... Clinical and Translational Medicine 13 (11), 2023 | 1 | 2023 |
| 217 Time-to-event machine learning prediction of metastatic recurrence of localized melanoma G Wan, B Leung, M DeSimone, N Nguyen, A Rajeh, M Collier, H Rashdan, ... Journal of Investigative Dermatology 143 (5), S37, 2023 | 1 | 2023 |
| Patterns in utilization of health care services and medications among patients with cutaneous immune-related adverse events: A population-level cohort study BW Leung, MR Collier, BC Tiu, G Wan, N Nguyen, K Tang, S Zhang, ... Journal of the American Academy of Dermatology 88 (5), 1215-1218, 2023 | 1 | 2023 |
| The impact of stage-related features in melanoma recurrence prediction: A machine learning approach G Wan, B Leung, N Nguyen, MS DeSimone, F Liu, MS Choi, D Ho, ... JAAD international 10, 28-30, 2023 | 1 | 2023 |
| 215 Cutaneous immune-related adverse events predict longer patient survival in advanced cancer patients C Lu, S Zhang, K Tang, P Ugwu-Dike, N Raval, J Seo, G Wan, N Nguyen, ... Journal of Investigative Dermatology 142 (8), S36, 2022 | 1 | 2022 |
Guihong WanHarvard Medical School; Massachusetts General HospitalVerified email at mgh.harvard.edu
